Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations

Detalhes bibliográficos
Autor(a) principal: Ferreira, Paulo Michel Pinheiro
Data de Publicação: 2016
Outros Autores: Bezerra, Daniel Pereira, Silva, Jurandy do Nascimento, Costa, Marcília Pinheiro da, Ferreira, José Roberto de Oliveira, Alencar, Nylane Maria Nunes, Figueiredo, Ingrid Samantha Tavares de, Cavalheiro, Alberto José, Machado, Camila Maria Longo, Chammas, Roger, Alves, Ana Paula Negreiros Nunes, Moraes, Manoel Odorico de, Pessoa, Claudia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/18081
Resumo: Federal Brazilian agency “Conselho Nacional de Desenvolvimento Científico e Tecnológico” (CNPq) for financial supportin the form of grants (#473167/2012-3) and fellowship (#301976/2013-9)
id CRUZ_a2cb9623638bf9530a3fbb5f450d068b
oai_identifier_str oai:www.arca.fiocruz.br:icict/18081
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Ferreira, Paulo Michel PinheiroBezerra, Daniel PereiraSilva, Jurandy do NascimentoCosta, Marcília Pinheiro daFerreira, José Roberto de OliveiraAlencar, Nylane Maria NunesFigueiredo, Ingrid Samantha Tavares deCavalheiro, Alberto JoséMachado, Camila Maria LongoChammas, RogerAlves, Ana Paula Negreiros NunesMoraes, Manoel Odorico dePessoa, Claudia2017-03-20T17:15:41Z2017-03-20T17:15:41Z2016FERREIRA, P. M. P. et al. Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations. Journal of Ethnopharmacology, v. 186, p. 270–279, 2016.0378-8741https://www.arca.fiocruz.br/handle/icict/1808110.1016/j.jep.2016.04.011Federal Brazilian agency “Conselho Nacional de Desenvolvimento Científico e Tecnológico” (CNPq) for financial supportin the form of grants (#473167/2012-3) and fellowship (#301976/2013-9)Federal University of Piauí. Laboratory in Experimental Cancerology. Department of Biophysics and Physiology.Teresina, PI, Brazil / Federal University of Piauí. Postgraduate Programin Pharmaceutical Sciences. Teresina, PI, Brazil / Federal University of Piauí. Postgraduate Programin in Biotechnology. Teresina, PI, BrazilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFederal University of Piauí. Postgraduate Programin in Biotechnology. Teresina, PI, BrazilFederal University of Piauí. Postgraduate Programin Pharmaceutical Sciences. Teresina, PI, Brazil / Federal University of Piauí. Department of Pharmacy. Teresina, PI, BrazilFederal University of Piauí. Postgraduate Programin Pharmaceutical Sciences. Teresina, PI, BrazilFederal University of Ceará. Faculty of Medicine. Department of Physiology and Pharmacology. Fortaleza, CE, BrazilFederal University of Ceará. Faculty of Medicine. Department of Physiology and Pharmacology. Fortaleza, CE, BrazilState University of São Paulo. Chemistry Institute. Araraquara, SP, BrazilState University of SãoPaulo. Center for Medical Nuclear. Radioisotopes Research Laboratory. São Paulo, SP, BrazilState University of Paulo. São Faculty of Medicine. Department of Radiology. São Paulo, SP, BrazilFederal University of Ceará. Department of Clinical Odontology. Fortaleza, CE, BrazilFederal University of Ceará. Faculty of Medicine. Department of Physiology and Pharmacology. Fortaleza, CE, BrazilFederal University of Ceará. Faculty of Medicine. Department of Physiology and Pharmacology. Fortaleza, CE, Brazil / Oswaldo Cruz Foundation. Fortaleza, CE, BrazilCasearia sylvestris (Salicaceae) is found in South America and presents antiulcerogenic, cytotoxic, antimicrobial, anti-inflammatory and antihypertensive activities. Aim ofthestudy: Toassessthe in vivoandexvivo antitumor actionofafractionwithcasearins(FC)andits main component-CasearinX-isolatedfrom C. sylvestris leaves. Materials andmethods: Firstly,Sarcoma180bearingSwissmiceweretreatedwithFCandCasXfor 7 days.Secondly,BALB/cnudeanimalsreceivedhollow fibers withcoloncarcinoma(HCT-116)orglio- blastoma (SF-295)cellsandweretreatedwithFCfor4days.On5thday,proliferationwasdeterminedby MTT assay. Results: FC 10and25mg/kg/dayi.p.and50mg/kg/dayoralandCasX25mg/kg/dayi.p.and50mg/kg/ day oralrevealedtumorgrowthinhibitionratesof35.8,86.2,53.7,90.0and65.5%andsuchtumors demonstratedraremitosesandcoagulationnecrosisareas.Similarly,FCreducedmultiplyingofHCT-116 and SF-295cellswhenevaluatedbytheHollowFiberAssay(2.5and5mg/kg/dayi.p.and25and50mg/ kg/day oral),withcellgrowthinhibitionratesrangingfrom33.3to67.4%(po0.05). Flowcytometry experimentsrevealedthatFCreducedmembraneintegrityandinducedDNAfragmentationandmi- tochondrial depolarization(po0.05). Conclusions: FC andCasXwereefficient antitumorsubstancesagainstmurineandhumancancercells and causedreversiblemorphologicalchangesinliver,kidneysandspleens,emphasizingclerodanedi- terpenes asanemergingclassofanticancermolecules.engElsevierCasearin XTeste de fibra ocaSarcoma 180LeucogramaAntineoplásicoCasearin XHollow fiber assaySarcoma 180AntineoplasticLeukogramPreclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinationsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/18081/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALFerreira PMP Preclinical anticancer....pdfFerreira PMP Preclinical anticancer....pdfapplication/pdf2237873https://www.arca.fiocruz.br/bitstream/icict/18081/2/Ferreira%20PMP%20Preclinical%20anticancer....pdfa782fd405e610e2b72306305766c0c3bMD52TEXTFerreira PMP Preclinical anticancer....pdf.txtFerreira PMP Preclinical anticancer....pdf.txtExtracted texttext/plain56786https://www.arca.fiocruz.br/bitstream/icict/18081/3/Ferreira%20PMP%20Preclinical%20anticancer....pdf.txtf1cfb942726cacf4ff075e54ac8d0631MD53icict/180812023-03-15 14:33:28.941oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:28Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
title Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
spellingShingle Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
Ferreira, Paulo Michel Pinheiro
Casearin X
Teste de fibra oca
Sarcoma 180
Leucograma
Antineoplásico
Casearin X
Hollow fiber assay
Sarcoma 180
Antineoplastic
Leukogram
title_short Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
title_full Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
title_fullStr Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
title_full_unstemmed Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
title_sort Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
author Ferreira, Paulo Michel Pinheiro
author_facet Ferreira, Paulo Michel Pinheiro
Bezerra, Daniel Pereira
Silva, Jurandy do Nascimento
Costa, Marcília Pinheiro da
Ferreira, José Roberto de Oliveira
Alencar, Nylane Maria Nunes
Figueiredo, Ingrid Samantha Tavares de
Cavalheiro, Alberto José
Machado, Camila Maria Longo
Chammas, Roger
Alves, Ana Paula Negreiros Nunes
Moraes, Manoel Odorico de
Pessoa, Claudia
author_role author
author2 Bezerra, Daniel Pereira
Silva, Jurandy do Nascimento
Costa, Marcília Pinheiro da
Ferreira, José Roberto de Oliveira
Alencar, Nylane Maria Nunes
Figueiredo, Ingrid Samantha Tavares de
Cavalheiro, Alberto José
Machado, Camila Maria Longo
Chammas, Roger
Alves, Ana Paula Negreiros Nunes
Moraes, Manoel Odorico de
Pessoa, Claudia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferreira, Paulo Michel Pinheiro
Bezerra, Daniel Pereira
Silva, Jurandy do Nascimento
Costa, Marcília Pinheiro da
Ferreira, José Roberto de Oliveira
Alencar, Nylane Maria Nunes
Figueiredo, Ingrid Samantha Tavares de
Cavalheiro, Alberto José
Machado, Camila Maria Longo
Chammas, Roger
Alves, Ana Paula Negreiros Nunes
Moraes, Manoel Odorico de
Pessoa, Claudia
dc.subject.other.pt_BR.fl_str_mv Casearin X
Teste de fibra oca
Sarcoma 180
Leucograma
Antineoplásico
topic Casearin X
Teste de fibra oca
Sarcoma 180
Leucograma
Antineoplásico
Casearin X
Hollow fiber assay
Sarcoma 180
Antineoplastic
Leukogram
dc.subject.en.pt_BR.fl_str_mv Casearin X
Hollow fiber assay
Sarcoma 180
Antineoplastic
Leukogram
description Federal Brazilian agency “Conselho Nacional de Desenvolvimento Científico e Tecnológico” (CNPq) for financial supportin the form of grants (#473167/2012-3) and fellowship (#301976/2013-9)
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2017-03-20T17:15:41Z
dc.date.available.fl_str_mv 2017-03-20T17:15:41Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FERREIRA, P. M. P. et al. Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations. Journal of Ethnopharmacology, v. 186, p. 270–279, 2016.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/18081
dc.identifier.issn.pt_BR.fl_str_mv 0378-8741
dc.identifier.doi.none.fl_str_mv 10.1016/j.jep.2016.04.011
identifier_str_mv FERREIRA, P. M. P. et al. Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations. Journal of Ethnopharmacology, v. 186, p. 270–279, 2016.
0378-8741
10.1016/j.jep.2016.04.011
url https://www.arca.fiocruz.br/handle/icict/18081
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/18081/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/18081/2/Ferreira%20PMP%20Preclinical%20anticancer....pdf
https://www.arca.fiocruz.br/bitstream/icict/18081/3/Ferreira%20PMP%20Preclinical%20anticancer....pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
a782fd405e610e2b72306305766c0c3b
f1cfb942726cacf4ff075e54ac8d0631
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009075524337664